世界のブチルスコポラミン臭化物市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Butylscopolamine Bromide Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1046 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ブチルスコポラミン臭化物のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル、筋肉内注射、静脈注射/点滴、坐薬、その他）、用途別市場規模（胃、ガスバリウムハイポグラフィー、腹部CTスキャン、胃腸痙攣、胆石発作、腎疝痛、胃腸運動亢進、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ブチルスコポラミン臭化物の市場動向 ・企業の競争状況、市場シェア ・ブチルスコポラミン臭化物の種類別市場規模（錠剤、カプセル、筋肉内注射、静脈注射/点滴、坐薬、その他） ・ブチルスコポラミン臭化物の用途別市場規模（胃、ガスバリウムハイポグラフィー、腹部CTスキャン、胃腸痙攣、胆石発作、腎疝痛、胃腸運動亢進、その他） ・ブチルスコポラミン臭化物の北米市場規模2016-2027（アメリカ、カナダ） ・ブチルスコポラミン臭化物のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ブチルスコポラミン臭化物のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ブチルスコポラミン臭化物の中南米市場規模2016-2027（メキシコ、ブラジル） ・ブチルスコポラミン臭化物の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Boehringer Ingelheim、Sandoz (Novartis)、Boehringer Ingelheim Pharma GmbH & Co. KG、XI AN TIANXINGJIAN PHARMCHEM、Linnea、Alkaloida、Chengdu Tiantaishan Pharmaceutical、Jiangsu Ange Pharmaceutical、Chengdu First Pharmaceutical、Beijing Zizhu Pharmaceutical、Guangdong Zhongsheng Pharmaceutical、Wanbangde Pharmaceutical Group、Shandong Yijian Pharmaceutical） ・結論

Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.

Market Analysis and Insights: Global Butylscopolamine Bromide Market
The global Butylscopolamine Bromide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Butylscopolamine Bromide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Butylscopolamine Bromide market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Butylscopolamine Bromide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Butylscopolamine Bromide market.

Global Butylscopolamine Bromide Scope and Market Size
Butylscopolamine Bromide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Butylscopolamine Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Capsule
Intramuscular Injection
Intravenous Or Drip
Suppositories
Other

Segment by Application
Stomach
Gas Barium Hypography
Abdominal CT Scan
Gastrointestinal Spasm
Biliary Colic
Renal Colic
Gastrointestinal Hypermotility
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Boehringer Ingelheim
Sandoz (Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan Pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Butylscopolamine Bromide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Intramuscular Injection
1.2.5 Intravenous Or Drip
1.2.6 Suppositories
1.2.7 Other
1.3 Market by Application
1.3.1 Global Butylscopolamine Bromide Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stomach
1.3.3 Gas Barium Hypography
1.3.4 Abdominal CT Scan
1.3.5 Gastrointestinal Spasm
1.3.6 Biliary Colic
1.3.7 Renal Colic
1.3.8 Gastrointestinal Hypermotility
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Butylscopolamine Bromide Market Perspective (2016-2027)
2.2 Butylscopolamine Bromide Growth Trends by Regions
2.2.1 Butylscopolamine Bromide Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Butylscopolamine Bromide Historic Market Share by Regions (2016-2021)
2.2.3 Butylscopolamine Bromide Forecasted Market Size by Regions (2022-2027)
2.3 Butylscopolamine Bromide Industry Dynamic
2.3.1 Butylscopolamine Bromide Market Trends
2.3.2 Butylscopolamine Bromide Market Drivers
2.3.3 Butylscopolamine Bromide Market Challenges
2.3.4 Butylscopolamine Bromide Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Butylscopolamine Bromide Players by Revenue
3.1.1 Global Top Butylscopolamine Bromide Players by Revenue (2016-2021)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Players (2016-2021)
3.2 Global Butylscopolamine Bromide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Butylscopolamine Bromide Revenue
3.4 Global Butylscopolamine Bromide Market Concentration Ratio
3.4.1 Global Butylscopolamine Bromide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Butylscopolamine Bromide Revenue in 2020
3.5 Butylscopolamine Bromide Key Players Head office and Area Served
3.6 Key Players Butylscopolamine Bromide Product Solution and Service
3.7 Date of Enter into Butylscopolamine Bromide Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Butylscopolamine Bromide Breakdown Data by Type
4.1 Global Butylscopolamine Bromide Historic Market Size by Type (2016-2021)
4.2 Global Butylscopolamine Bromide Forecasted Market Size by Type (2022-2027)

5 Butylscopolamine Bromide Breakdown Data by Application
5.1 Global Butylscopolamine Bromide Historic Market Size by Application (2016-2021)
5.2 Global Butylscopolamine Bromide Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Butylscopolamine Bromide Market Size (2016-2027)
6.2 North America Butylscopolamine Bromide Market Size by Type
6.2.1 North America Butylscopolamine Bromide Market Size by Type (2016-2021)
6.2.2 North America Butylscopolamine Bromide Market Size by Type (2022-2027)
6.2.3 North America Butylscopolamine Bromide Market Size by Type (2016-2027)
6.3 North America Butylscopolamine Bromide Market Size by Application
6.3.1 North America Butylscopolamine Bromide Market Size by Application (2016-2021)
6.3.2 North America Butylscopolamine Bromide Market Size by Application (2022-2027)
6.3.3 North America Butylscopolamine Bromide Market Size by Application (2016-2027)
6.4 North America Butylscopolamine Bromide Market Size by Country
6.4.1 North America Butylscopolamine Bromide Market Size by Country (2016-2021)
6.4.2 North America Butylscopolamine Bromide Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Butylscopolamine Bromide Market Size (2016-2027)
7.2 Europe Butylscopolamine Bromide Market Size by Type
7.2.1 Europe Butylscopolamine Bromide Market Size by Type (2016-2021)
7.2.2 Europe Butylscopolamine Bromide Market Size by Type (2022-2027)
7.2.3 Europe Butylscopolamine Bromide Market Size by Type (2016-2027)
7.3 Europe Butylscopolamine Bromide Market Size by Application
7.3.1 Europe Butylscopolamine Bromide Market Size by Application (2016-2021)
7.3.2 Europe Butylscopolamine Bromide Market Size by Application (2022-2027)
7.3.3 Europe Butylscopolamine Bromide Market Size by Application (2016-2027)
7.4 Europe Butylscopolamine Bromide Market Size by Country
7.4.1 Europe Butylscopolamine Bromide Market Size by Country (2016-2021)
7.4.2 Europe Butylscopolamine Bromide Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Butylscopolamine Bromide Market Size (2016-2027)
8.2 Asia-Pacific Butylscopolamine Bromide Market Size by Type
8.2.1 Asia-Pacific Butylscopolamine Bromide Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Butylscopolamine Bromide Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Butylscopolamine Bromide Market Size by Type (2016-2027)
8.3 Asia-Pacific Butylscopolamine Bromide Market Size by Application
8.3.1 Asia-Pacific Butylscopolamine Bromide Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Butylscopolamine Bromide Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Butylscopolamine Bromide Market Size by Application (2016-2027)
8.4 Asia-Pacific Butylscopolamine Bromide Market Size by Region
8.4.1 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Butylscopolamine Bromide Market Size (2016-2027)
9.2 Latin America Butylscopolamine Bromide Market Size by Type
9.2.1 Latin America Butylscopolamine Bromide Market Size by Type (2016-2021)
9.2.2 Latin America Butylscopolamine Bromide Market Size by Type (2022-2027)
9.2.3 Latin America Butylscopolamine Bromide Market Size by Type (2016-2027)
9.3 Latin America Butylscopolamine Bromide Market Size by Application
9.3.1 Latin America Butylscopolamine Bromide Market Size by Application (2016-2021)
9.3.2 Latin America Butylscopolamine Bromide Market Size by Application (2022-2027)
9.3.3 Latin America Butylscopolamine Bromide Market Size by Application (2016-2027)
9.4 Latin America Butylscopolamine Bromide Market Size by Country
9.4.1 Latin America Butylscopolamine Bromide Market Size by Country (2016-2021)
9.4.2 Latin America Butylscopolamine Bromide Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Butylscopolamine Bromide Market Size (2016-2027)
10.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type
10.2.1 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Butylscopolamine Bromide Market Size by Type (2016-2027)
10.3 Middle East & Africa Butylscopolamine Bromide Market Size by Application
10.3.1 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Butylscopolamine Bromide Market Size by Application (2016-2027)
10.4 Middle East & Africa Butylscopolamine Bromide Market Size by Country
10.4.1 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Butylscopolamine Bromide Introduction
11.1.4 Sanofi Revenue in Butylscopolamine Bromide Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Introduction
11.2.4 Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Introduction
11.3.4 Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2016-2021)
11.3.5 Sandoz (Novartis) Recent Development
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Introduction
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2016-2021)
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Details
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Business Overview
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Introduction
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2016-2021)
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Recent Development
11.6 Linnea
11.6.1 Linnea Company Details
11.6.2 Linnea Business Overview
11.6.3 Linnea Butylscopolamine Bromide Introduction
11.6.4 Linnea Revenue in Butylscopolamine Bromide Business (2016-2021)
11.6.5 Linnea Recent Development
11.7 Alkaloida
11.7.1 Alkaloida Company Details
11.7.2 Alkaloida Business Overview
11.7.3 Alkaloida Butylscopolamine Bromide Introduction
11.7.4 Alkaloida Revenue in Butylscopolamine Bromide Business (2016-2021)
11.7.5 Alkaloida Recent Development
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Details
11.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Introduction
11.8.4 Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.8.5 Chengdu Tiantaishan Pharmaceutical Recent Development
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Details
11.9.2 Jiangsu Ange Pharmaceutical Business Overview
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Introduction
11.9.4 Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.9.5 Jiangsu Ange Pharmaceutical Recent Development
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Details
11.10.2 Chengdu First Pharmaceutical Business Overview
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Introduction
11.10.4 Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.10.5 Chengdu First Pharmaceutical Recent Development
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Details
11.11.2 Beijing Zizhu Pharmaceutical Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Introduction
11.11.4 Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.11.5 Beijing Zizhu Pharmaceutical Recent Development
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Details
11.12.2 Guangdong Zhongsheng Pharmaceutical Business Overview
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Introduction
11.12.4 Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.12.5 Guangdong Zhongsheng Pharmaceutical Recent Development
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Details
11.13.2 Wanbangde Pharmaceutical Group Business Overview
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Introduction
11.13.4 Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2016-2021)
11.13.5 Wanbangde Pharmaceutical Group Recent Development
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Details
11.14.2 Shandong Yijian Pharmaceutical Business Overview
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Introduction
11.14.4 Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021)
11.14.5 Shandong Yijian Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Butylscopolamine Bromide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Capsule
Table 4. Key Players of Intramuscular Injection
Table 5. Key Players of Intravenous Or Drip
Table 6. Key Players of Suppositories
Table 7. Key Players of Other
Table 8. Global Butylscopolamine Bromide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Butylscopolamine Bromide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Butylscopolamine Bromide Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Butylscopolamine Bromide Market Share by Regions (2016-2021)
Table 12. Global Butylscopolamine Bromide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Butylscopolamine Bromide Market Share by Regions (2022-2027)
Table 14. Butylscopolamine Bromide Market Trends
Table 15. Butylscopolamine Bromide Market Drivers
Table 16. Butylscopolamine Bromide Market Challenges
Table 17. Butylscopolamine Bromide Market Restraints
Table 18. Global Butylscopolamine Bromide Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Butylscopolamine Bromide Market Share by Players (2016-2021)
Table 20. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Butylscopolamine Bromide as of 2020)
Table 21. Ranking of Global Top Butylscopolamine Bromide Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Butylscopolamine Bromide Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Butylscopolamine Bromide Product Solution and Service
Table 25. Date of Enter into Butylscopolamine Bromide Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Butylscopolamine Bromide Revenue Market Share by Type (2016-2021)
Table 29. Global Butylscopolamine Bromide Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Butylscopolamine Bromide Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Butylscopolamine Bromide Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Butylscopolamine Bromide Revenue Market Share by Application (2016-2021)
Table 33. Global Butylscopolamine Bromide Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Butylscopolamine Bromide Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Butylscopolamine Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Butylscopolamine Bromide Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Butylscopolamine Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Butylscopolamine Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Butylscopolamine Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Butylscopolamine Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Butylscopolamine Bromide Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Butylscopolamine Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Butylscopolamine Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Butylscopolamine Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Butylscopolamine Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Butylscopolamine Bromide Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Butylscopolamine Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Butylscopolamine Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Butylscopolamine Bromide Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Butylscopolamine Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Butylscopolamine Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Butylscopolamine Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Butylscopolamine Bromide Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Butylscopolamine Bromide Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Butylscopolamine Bromide Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Butylscopolamine Bromide Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2022-2027) & (US$ Million)
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Butylscopolamine Bromide Product
Table 68. Sanofi Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 69. Sanofi Recent Development
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Butylscopolamine Bromide Product
Table 73. Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Sandoz (Novartis) Company Details
Table 76. Sandoz (Novartis) Business Overview
Table 77. Sandoz (Novartis) Butylscopolamine Bromide Product
Table 78. Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 79. Sandoz (Novartis) Recent Development
Table 80. Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
Table 81. Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
Table 82. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product
Table 83. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 84. Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
Table 85. XI AN TIANXINGJIAN PHARMCHEM Company Details
Table 86. XI AN TIANXINGJIAN PHARMCHEM Business Overview
Table 87. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product
Table 88. XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 89. XI AN TIANXINGJIAN PHARMCHEM Recent Development
Table 90. Linnea Company Details
Table 91. Linnea Business Overview
Table 92. Linnea Butylscopolamine Bromide Product
Table 93. Linnea Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 94. Linnea Recent Development
Table 95. Alkaloida Company Details
Table 96. Alkaloida Business Overview
Table 97. Alkaloida Butylscopolamine Bromide Product
Table 98. Alkaloida Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 99. Alkaloida Recent Development
Table 100. Chengdu Tiantaishan Pharmaceutical Company Details
Table 101. Chengdu Tiantaishan Pharmaceutical Business Overview
Table 102. Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 103. Chengdu Tiantaishan Pharmaceutical Recent Development
Table 104. Jiangsu Ange Pharmaceutical Company Details
Table 105. Jiangsu Ange Pharmaceutical Business Overview
Table 106. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product
Table 107. Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 108. Jiangsu Ange Pharmaceutical Recent Development
Table 109. Chengdu First Pharmaceutical Company Details
Table 110. Chengdu First Pharmaceutical Business Overview
Table 111. Chengdu First Pharmaceutical Butylscopolamine Bromide Product
Table 112. Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 113. Chengdu First Pharmaceutical Recent Development
Table 114. Beijing Zizhu Pharmaceutical Company Details
Table 115. Beijing Zizhu Pharmaceutical Business Overview
Table 116. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product
Table 117. Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 118. Beijing Zizhu Pharmaceutical Recent Development
Table 119. Guangdong Zhongsheng Pharmaceutical Company Details
Table 120. Guangdong Zhongsheng Pharmaceutical Business Overview
Table 121. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product
Table 122. Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 123. Guangdong Zhongsheng Pharmaceutical Recent Development
Table 124. Wanbangde Pharmaceutical Group Company Details
Table 125. Wanbangde Pharmaceutical Group Business Overview
Table 126. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product
Table 127. Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 128. Wanbangde Pharmaceutical Group Recent Development
Table 129. Shandong Yijian Pharmaceutical Company Details
Table 130. Shandong Yijian Pharmaceutical Business Overview
Table 131. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product
Table 132. Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2016-2021) & (US$ Million)
Table 133. Shandong Yijian Pharmaceutical Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Butylscopolamine Bromide Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Intramuscular Injection Features
Figure 5. Intravenous Or Drip Features
Figure 6. Suppositories Features
Figure 7. Other Features
Figure 8. Global Butylscopolamine Bromide Market Share by Application: 2020 VS 2027
Figure 9. Stomach Case Studies
Figure 10. Gas Barium Hypography Case Studies
Figure 11. Abdominal CT Scan Case Studies
Figure 12. Gastrointestinal Spasm Case Studies
Figure 13. Biliary Colic Case Studies
Figure 14. Renal Colic Case Studies
Figure 15. Gastrointestinal Hypermotility Case Studies
Figure 16. Other Case Studies
Figure 17. Butylscopolamine Bromide Report Years Considered
Figure 18. Global Butylscopolamine Bromide Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Butylscopolamine Bromide Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Butylscopolamine Bromide Market Share by Regions: 2020 VS 2027
Figure 21. Global Butylscopolamine Bromide Market Share by Regions (2022-2027)
Figure 22. Global Butylscopolamine Bromide Market Share by Players in 2020
Figure 23. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Butylscopolamine Bromide as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Butylscopolamine Bromide Revenue in 2020
Figure 25. Global Butylscopolamine Bromide Revenue Market Share by Type (2016-2021)
Figure 26. Global Butylscopolamine Bromide Revenue Market Share by Type (2022-2027)
Figure 27. North America Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Butylscopolamine Bromide Market Share by Type (2016-2027)
Figure 29. North America Butylscopolamine Bromide Market Share by Application (2016-2027)
Figure 30. North America Butylscopolamine Bromide Market Share by Country (2016-2027)
Figure 31. United States Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Butylscopolamine Bromide Market Share by Type (2016-2027)
Figure 35. Europe Butylscopolamine Bromide Market Share by Application (2016-2027)
Figure 36. Europe Butylscopolamine Bromide Market Share by Country (2016-2027)
Figure 37. Germany Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Butylscopolamine Bromide Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Butylscopolamine Bromide Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Butylscopolamine Bromide Market Share by Region (2016-2027)
Figure 47. China Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Butylscopolamine Bromide Market Share by Type (2016-2027)
Figure 55. Latin America Butylscopolamine Bromide Market Share by Application (2016-2027)
Figure 56. Latin America Butylscopolamine Bromide Market Share by Country (2016-2027)
Figure 57. Mexico Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Butylscopolamine Bromide Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Butylscopolamine Bromide Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Butylscopolamine Bromide Market Share by Country (2016-2027)
Figure 63. Turkey Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Butylscopolamine Bromide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. Sanofi Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 68. Sandoz (Novartis) Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 69. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 70. XI AN TIANXINGJIAN PHARMCHEM Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 71. Linnea Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 72. Alkaloida Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 73. Chengdu Tiantaishan Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 74. Jiangsu Ange Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 75. Chengdu First Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 76. Beijing Zizhu Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 77. Guangdong Zhongsheng Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 78. Wanbangde Pharmaceutical Group Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 79. Shandong Yijian Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---